June, 2010 ExAblate received CE mark approval for treating Adenomyosis.
Uterine fibroids (also referred to as myomas, leiomyomas, leiomyomata, and fibromyomas) are benign (non-cancerous) tumors that grow within the muscle tissue of the uterus. They are the most common pelvic tumors in women, with a prevalence of 20-40% in women of reproductive age. Fibroids occur at a higher rate among women of African-American descent. While many women with fibroids do not experience any symptoms, the location and size of fibroids can change and cause symptoms that can affect a woman’s quality of life.
ExAblate using MR guided focused ultrasound for treating uterine fibroids
ExAblate is the first and only commercially approved focused ultrasound therapeutic application for uterine fibroids.
Magnetic Resonance guided Focused Ultrasound (MRgFUS) has been demonstrated as a viable option for effectively treating uterine fibroids.
Compared to traditional hysterectomy, which is the primary treatment option for uterine fibroids, MRgFUS offers both clinical and economic advantages. Because it is a non-invasive procedure, patients avoid the risks associated with surgery, require only limited conscious sedation, and can return to normal activities the next day compared to lengthy recovery times and hospitalization days for the more traditional hysterectomy surgery. This translates into a significant economic impact for patients who undergo the MRgFUS procedure with documented fewer disability days (decreased days of missed work or days in bed) and lower use of medical resources: 83% fewer physician visits, 66% fewer additional diagnostic tests, and 66% fewer additional procedures.
Benefits of ExAblate for treating fibroids
- It’s a non-invasive outpatient procedure meaning patients do not require overnight hospital stays.
- Patients are able to go back to work the following day.
- Localized targeting and deposit of therapeutic energy is limited to the inside of the fibroid capsule.
- There are no treatment effects to the surrounding uterine tissue.
- The physician is able to see the effects of the treatment immediately after the procedure.
- Low incidence of complications
- No radiation exposure
For women who suffer from symptomatic uterine fibroids, please see our patients' website, http://www.uterine-fibroids.org/
For more information please contact us
